Given that p53 mutation and EGFR and HER2 overexpression are common occurrences in oesophageal adenocarcinoma, and that ERs interact with all three of these molecules, understanding this relationship may have implications for treatment response. The gene discussed is ERBB2; the disease is esophageal adenocarcinoma.